Although further investigations might be necessary to assess the risk of tumorigenic transformation that could be caused by application of the MSC undergoing long-term ex vivo expansion, our data suggest that elevated expression of c-MYC alone did not immediately lead to tumor formation in the tested in vivo mouse model. The gene discussed is MYC; the disease is neoplasm.